Target intelligence / Profile preview

Gastrointestinal tract microbiota modulation

Molecular classification
Other
01

Overview

Gastrointestinal tract microbiota modulation refers to the intentional alteration—through dietary changes, supplementation with specific microorganisms like probiotics/prebiotics, fecal transplants, phage therapy, or other targeted interventions—of the complex community structure and function formed by trillions of microorganisms inhabiting the human digestive tract. This ecosystem includes bacteria, archaea, fungi, and viruses that collectively influence digestion/metabolism; shape local and systemic immunity; maintain intestinal barrier integrity; produce key bioactive compounds such as short-chain fatty acids; modulate inflammation; affect neurological processes via the gut-brain axis; and directly interact with drugs through metabolic transformation. Imbalances in this ecosystem (“dysbiosis”) are linked to a wide range of diseases from gastrointestinal disorders like IBD/IBS/CDI to metabolic syndromes and neurodegeneration. Therapeutic strategies aim either at restoring balance after disruption or at shifting the community toward a configuration associated with health benefits. However—as “modulation” is an intervention strategy rather than a discrete molecular entity—it is not considered a canonical therapeutic target like an enzyme/receptor/transporter but rather describes approaches targeting an entire ecological system within the body.[1][2][3][4][6] **Note:** The entry "Gastrointestinal tract microbiota modulation" does not refer to a single molecule/receptor/protein but instead describes an intervention strategy targeting a complex biological system. Therefore it should be marked as **not a canonical target** (`is_target: false`) and **incorrect** for standard molecular target listings (`is_incorrect: true`).

Other names
Gut microbiota modulationGut microbiome modulationModulation of gut floraMicrobiome manipulation
02

Mechanism of action

– Restoration or alteration of microbial community composition to a healthier state via introduction or promotion of beneficial microbes[1][2] – Suppression or elimination of pathogenic bacteria using bacteriophages or competitive exclusion by commensals[2] – Enhancement/modulation of host immune responses through microbial metabolites and cell signaling pathways[4]

03

Biological functions

Regulation of nutrient metabolismModulation of immune responseMaintenance of gut barrier integrityInfluence on drug metabolismProduction of bioactive metabolites
04

Disease associations

Inflammatory bowel disease (IBD)Irritable bowel syndrome (IBS)Clostridioides difficile infection (CDI)Metabolic disorders (e.g., obesity, diabetes)Neurodegenerative diseases (e.g., Alzheimer’s disease)CancerInfection
05

Safety considerations

Risk of infection transmission with FMT proceduresPotential for adverse immune reactions to introduced microbesUnpredictable effects due to individual variability in baseline microbiome compositionLong-term safety data lacking for many interventions
06

Interacting drugs

Probiotics (e.g., Lactobacillus rhamnosus, Saccharomyces boulardii, E. coli Nissle 1917)[2]

4 more in the full profile.

07

Biomarkers

Short-chain fatty acids (SCFAs) such as butyrate and propionate levels in stool/serum[6]Bile acid profiles modified by bacterial activity[6]Tryptophan metabolites including indole derivatives reflecting both host and microbial metabolism[6]

Beyond the preview

Go deeper on Gastrointestinal tract microbiota modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal tract microbiota modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call